The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China
NCT06557304
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
CLL
Interventions
DRUG:
BTK inhibitor
Sponsor
Peking University People's Hospital